Ahlquist RP. A study of the adrenotropic receptors. Am J Physiol. 1948;153(3):586-600.
Wenger NK, Greenbaum LM. From adrenoceptor mechanisms to clinical therapeutics: Raymond Ahlquist, Ph.D., 1914-1983. J Am Coll Cardiol. 1984;3(2 Pt 1):419-421.
Limbird LE. Historical perspective for understanding of adrenergic receptors. Curr Top Membr. 2011;67:1-17.
Wachter SB, Gilbert EM. Beta-adrenergic receptors, from their discovery and characterization through their manipulation to beneficial clinical application. Cardiology. 2012;122(2):104-112.
Fontanarosa P, Bauchner H, Flanagin A. Authorship and team science. JAMA. 2017;318(24):2433-2437
Berquist TH. Authorship creep: Do we need a new process. Am J Roentgenol. 2009;193:599-600
Berquist TH. Publication in biomedical journals: An example-based tutorial series, Part II: Was I really an author? Am J Roentgenol 2010;194:1411-1412.
Smith E, Williams-Jones B. Authorship and responsibility in health sciences research: a review of procedures for fairly allocating authorship in multi-author studies. Sci Eng Ethics. 2012;18(2):199-212.
Teixeira da Silva JA, Dobranszki J. Multiple authorship in scientific manuscripts: Ethical challenges, ghost and guest/gift authorship, and the cultural/disciplinary perspective. Sci Eng Ethics. 2016;22(5):1457-1472.
Hosseini M, Lewis J, Zwart H, Gordijn B. An ethical exploration of increased average number of authors per publication. Sci Eng Ethics. 2022;28(3):25.
Shader RI, Greenblatt DJ. Elements of a Good Scientific Paper. J Clin Psychopharmacol. 2016;36(6):539-541.
Justin GA, Pelton RW, Woreta FA, Legault GL. Authorship ethics: A practical approach. Am J Ophthalmol. 2021;224:A3-A5.
McNutt MK, Bradford M, Drazen JM, et al. Transparency in authors' contributions and responsibilities to promote integrity in scientific publication. Proc Natl Acad Sci U S A. 2018;115(11):2557-2560.
Quaia E, Crimi F. Honorary authorship: Is there any chance to stop it? Analysis of the literature and a personal opinion. Tomography. 2021;7(4):801-803.
Engle C. The ethics of authorship and preparation of research publications. J World Aquacult Soc. 2020;51:328-333.
Doherty M, Van De Putte LB. Committee on Publication Ethics (COPE) guidelines on good publication practice. Ann Rheum Dis. 2000;59(6):403-404.
Coats AJ. Ethical authorship and publishing. Int J Cardiol. 2009;131(2):149-150.
DeTora LM, Toroser D, Sykes A, et al. Good Publication Practice (GPP) guidelines for company-sponsored biomedical research: 2022 update. Ann Intern Med. 2022;175(9):1298-1304.
Jacobs A, Wager E. European Medical Writers Association (EMWA) guidelines on the role of medical writers in developing peer-reviewed publications. Curr Med Res Opin. 2005;21(2):317-322.
DeTora LM, Carey MA, Toroser D, Baum EZ. Ghostwriting in biomedicine: a review of the published literature. Curr Med Res Opin. 2019;35(9):1643-1651.
Stretton S. Systematic review on the primary and secondary reporting of the prevalence of ghostwriting in the medical literature. BMJ Open. 2014;4(7):e004777.
Matheson A. Ghostwriting: the importance of definition and its place in contemporary drug marketing. BMJ. 2016;354:i4578.
Gotzsche PC, Kassirer JP, Woolley KL, et al. What should be done to tackle ghostwriting in the medical literature? PLoS Med. 2009;6(2):e23.
Teixeira da Silva JA. ORCID: Issues and concerns about its use for academic purposes and research integrity. Ann Library Information Studies. 2020;67:246-250.
